发明名称 SUSTAINED RELEASE FORMULATIONS FOR THE TREATMENT OF INTRAOCULAR PRESSURE OR GLAUCOMA
摘要 The present embodiments provide for methods of treating elevated intraocular pressure or glaucoma using a sustained release medicament consisting of prostaglandin in benzyl benzoate that is injected intraocularly no more frequently than once every two months.
申请公布号 US2016151386(A1) 申请公布日期 2016.06.02
申请号 US201615018461 申请日期 2016.02.08
申请人 Icon Bioscience, Inc. 发明人 Wong Vernon G.;Hu Mae W.;Huang Glenn T.
分类号 A61K31/5575;A61K9/00 主分类号 A61K31/5575
代理机构 代理人
主权项 1. A liquid medicament for use in the treatment of elevated intraocular pressure or glaucoma in a subject, the medicament consisting of prostaglandin in benzyl benzoate, the prostaglandin present at about 0.1% (w/w) to about 5% (w/w), inclusive, the medicament for a dosing regimen in which about 5 μL to about 60 μL, inclusive, is injected into the anterior chamber or vitreous of the eye once per interval of no less than about two months.
地址 Sunnyvale CA US